Perella Weinberg Partners Capital Management LP bought a new stake in shares of Agilent Technologies Inc (NYSE:A) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 71,616 shares of the medical research company’s stock, valued at approximately $5,348,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Stratos Wealth Partners LTD. boosted its stake in shares of Agilent Technologies by 2.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 31,792 shares of the medical research company’s stock valued at $2,555,000 after purchasing an additional 850 shares in the last quarter. Prentiss Smith & Co. Inc. lifted its position in Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock valued at $4,363,000 after acquiring an additional 48,438 shares during the period. TimesSquare Capital Management LLC lifted its position in Agilent Technologies by 0.7% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,007,700 shares of the medical research company’s stock valued at $80,999,000 after acquiring an additional 7,200 shares during the period. Nordea Investment Management AB lifted its position in Agilent Technologies by 510.5% during the 1st quarter. Nordea Investment Management AB now owns 112,292 shares of the medical research company’s stock valued at $9,028,000 after acquiring an additional 93,898 shares during the period. Finally, Mason Street Advisors LLC lifted its position in Agilent Technologies by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 45,312 shares of the medical research company’s stock valued at $3,642,000 after acquiring an additional 370 shares during the period.
Agilent Technologies stock traded down $1.13 during trading hours on Friday, hitting $68.08. The stock had a trading volume of 2,803,508 shares, compared to its average volume of 2,744,409. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.82. The company has a market cap of $21.93 billion, a PE ratio of 24.40, a P/E/G ratio of 1.93 and a beta of 1.41. Agilent Technologies Inc has a 12-month low of $61.01 and a 12-month high of $82.27. The stock has a 50-day simple moving average of $71.82.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period last year, the firm posted $0.65 earnings per share. As a group, equities analysts forecast that Agilent Technologies Inc will post 3.05 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were issued a $0.164 dividend. The ex-dividend date of this dividend was Monday, July 1st. This represents a $0.66 annualized dividend and a yield of 0.96%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.66%.
A number of research analysts recently issued reports on A shares. Wolfe Research started coverage on shares of Agilent Technologies in a research report on Thursday, May 30th. They set a “peer perform” rating for the company. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Deutsche Bank lowered their price target on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. Barclays cut shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $86.00 to $78.00 in a research report on Monday, July 15th. Finally, Zacks Investment Research cut shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 price target for the company. in a research report on Tuesday, July 16th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company’s stock. Agilent Technologies has an average rating of “Buy” and an average price target of $83.92.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Read More: When can a hold rating present a buying opportunity?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.